Glenview Trust CO Novartis Ag Transaction History
Glenview Trust CO
- $5.13 Billion
- Q3 2024
A detailed history of Glenview Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Glenview Trust CO holds 3,707 shares of NVS stock, worth $366,918. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,707
Previous 3,695
0.32%
Holding current value
$366,918
Previous $393,000
8.4%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding NVS
# of Institutions
1,438Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.21 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.19 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$801 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$691 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$571 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $213B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...